updated taylor collison report, page-5

Hi Portable,

I am excited of the prospect of being in the best possible environment to conclude a deal for LANI, and not only that, but with 6 Big Pharmas in line trying to get it, we have to be on a winner.

My thoughts have always been $3 for our shares before the royalty Q3 announcement.

Then moving to $3.50 with a good royalty result and positive update on increased production of Relenza.

And with the delivery of a succesfull Lani deal with a good royalty rate attached to it, we could reach the $4 mark.

For now we nearly have the $3 in our pockets , and I will look forward to the $3.50 with the right Relenza royalty and production updates.

Good luck to all

jojo